Patient characteristic | B | S. E | Wals | OR | CI (95%) | P | |
---|---|---|---|---|---|---|---|
Clinical T stage | 3 | Ref | Â | Â | Â | Â | Â |
 | 1 + 2 | 0.668 | 0.355 | 3.543 | 1.950 | 0.973–3.909 | 0.060 |
HR status | ER + /PR +  | Ref |  |  |  |  |  |
 | ER + /PR- | 0.667 | 0.322 | 4.292 | 1.949 | 1.037–3.663 | 0.038 |
 | ER-/PR +  | 0.039 | 1.083 | 0.001 | 0.962 | 0.115–8.042 | 0.977 |
 | ER-/PR- | 0.992 | 0.237 | 17.523 | 2.697 | 1.695–4.292 |  < 0.001 |
HER-2 | Negative | Ref | Â | Â | Â | Â | Â |
 | Positive | 0.721 | 0.200 | 12.956 | 2.057 | 1.389–3.046 |  < 0.001 |
KI67 |  ≤ 15 | Ref |  |  |  |  |  |
 |  > 15 | 0.575 | 0.224 | 6.615 | 1.777 | 1.147–2.754 | 0.010 |
Stage | I + II | Ref |  |  |  |  |  |
 | III | 0.520 | 0.321 | 52.415 | 1.682 | 1.075–2.631 | 0.023 |